A new broker report came out last week with a share price target downgrade to around $3.60 BUT .....then went on to say how if the Bronchitol results (due July/Aug) are as good as expected then it adds over 60 cents to the valuation.
Veyr happy to hold this in anticipation of good results coming out. If positive, we should see the $3.70 threshold broken once and for all and hopefully a $4 floor.
